Kayne Anderson Rudnick Investment Management LLC Catalent, Inc. Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$87.2 - $114.05 $1,395 - $1,824	-16 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $1,507 - $1,991	16 New	16 $2,000
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $1,928 - $2,380	-19 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $1,631 - $2,001	19 New	19 $2,000

Others Institutions Holding CTLT

# of Institutions

515

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

Vanguard Group Inc Valley Forge, PA

20.2M
Shares

$1.25 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

15.4M
Shares

$947 Million
0.02% of portfolio
State Street Corp Boston, MA

7.45M
Shares

$460 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

6.4M
Shares

$395 Million
0.06% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.52M
Shares

$279 Million
0.14% of portfolio

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.1B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account